A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Friday 4 March 2011

Those four ECJ references: a short article

Via Neil J. Wilkof (Herzog Fox Neeman) comes news of "A Combination Problem - Scope of Protection of Supplementary Protection Certificates (SPC)". This article, penned by David Rose (partner and Head of Life Sciences at SJ Berwin LLP) is an earlier version of a piece which appeared in Scrip Pharma Law.

This three-page article, which you can access here, summarises the focal points of the four England and Wales SPC cases which have been referred for preliminary rulings by the Court of Justice of the European Union, emphasises their importance in defining the balance between the two sides of the pharma industry and doubts that the outstanding questions will be resolved in the course of this calendar year.

1 comment:

Anonymous said...

It's a shame this article missed the fifth reference (see blog entry below). The Queensland reference seems to be the most comprehensive.